Content Navigation
( All
None )
Target and Pathway |
Top |
Target(s) |
HUMAN PI3-kinase delta (PIK3CD) |
Target Info
|
Inhibitor |
[2] |
HUMAN PI3-kinase gamma (PIK3CG) |
Target Info
|
Inhibitor |
[2] |
References |
Top |
REF 1 |
FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (NDA) 211155
|
REF 2 |
ClinicalTrials.gov (NCT04372602) Duvelisib to Combat COVID-19. U.S. National Institutes of Health.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.